Picture of IRADIMED logo

IRMD — IRADIMED News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

IRadimed Corp reports results for the quarter ended in March - Earnings Summary

* IRadimed Corp  IRMD.OQ  reported quarterly adjusted earnings
of 13 cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for earnings of
10 cents per share.
* Revenue rose 6.3% to $9.22 million from a year ago​;  analysts
expected $8.56 million.
* IRadimed Corp's reported EPS for the quarter was 11 cents​.
* The mean earnings estimate of analysts had fallen by
about 33.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* IRadimed Corp shares had risen by 3.8% this quarter and
gained 17.4% so far this year.
* The company reported quarterly net income of $1.39 million.
* Wall Street's median 12-month price target for IRadimed Corp
is $29.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated April 30 at 05:23 p.m. GMT.
​All figures in US Dollars.​

Recent news on IRADIMED

See all news